C. difficile


C. difficile Infection in the Older Adult

November 11, 2021

An industry-supported symposium presented during the GSA 2021 Annual Scientific Meeting Online for a live audience. Sponsored by Pfizer.

C. difficile is a public health threat that is often under recognized and under diagnosed in patients around the world. In older adults aged 65+ years, C. difficile infections take the lives of 1 in 11 patients within a month of diagnosis. Commonly thought of as a disease associated with hospital settings, community-associated C. difficile infections are on the rise. It is important to understand the prevalence and persistence of C. difficile and how C. difficile disproportionately affects adult patients. During this symposium, a panel of experts will discuss the risks and clinical considerations regarding the management of C. difficile.


  • Erik R. Dubberke, MD, MSPH, Professor of Medicine, Clinical Director, Transplant Infectious Diseases, Washington University School of Medicine, Saint Louis, Missouri (Chair) 
  • Fayola Delica, BSHSE, BSN, RN, MSN-FNP(s), D. Min (Hon), Fayola Delica, LLC, Fort Lauderdale, Florida \
  • Ruth Carrico, PhD, DNP, FSHEA, FNAP, FAAN, Executive Director, Norton Infectious Diseases Institute, Norton Healthcare, Professor, gratis faculty, Division of Infectious Diseases, University of Louisville, Louisville, Kentucky
  • Stefan Gravenstein, MD, MPH, Professor of Medicine and Health Services Policy & Practice, David S. Greer Professor of Geriatric Medicine, Director, Division of Geriatrics and Palliative Medicine, Schools of Medicine and Public Health, Associate Director, COIN-LTSS, Providence, VAMC

Share This Page!

Print Page